Valiulienė, G.; Vitkevičienė, A.; Skliutė, G.; Borutinskaitė, V.; Navakauskienė, R.
Pharmaceutical Drug Metformin and MCL1 Inhibitor S63845 Exhibit Anticancer Activity in Myeloid Leukemia Cells via Redox Remodeling. Molecules 2021, 26, 2303.
https://doi.org/10.3390/molecules26082303
AMA Style
Valiulienė G, Vitkevičienė A, Skliutė G, Borutinskaitė V, Navakauskienė R.
Pharmaceutical Drug Metformin and MCL1 Inhibitor S63845 Exhibit Anticancer Activity in Myeloid Leukemia Cells via Redox Remodeling. Molecules. 2021; 26(8):2303.
https://doi.org/10.3390/molecules26082303
Chicago/Turabian Style
Valiulienė, Giedrė, Aida Vitkevičienė, Giedrė Skliutė, Veronika Borutinskaitė, and Rūta Navakauskienė.
2021. "Pharmaceutical Drug Metformin and MCL1 Inhibitor S63845 Exhibit Anticancer Activity in Myeloid Leukemia Cells via Redox Remodeling" Molecules 26, no. 8: 2303.
https://doi.org/10.3390/molecules26082303
APA Style
Valiulienė, G., Vitkevičienė, A., Skliutė, G., Borutinskaitė, V., & Navakauskienė, R.
(2021). Pharmaceutical Drug Metformin and MCL1 Inhibitor S63845 Exhibit Anticancer Activity in Myeloid Leukemia Cells via Redox Remodeling. Molecules, 26(8), 2303.
https://doi.org/10.3390/molecules26082303